Project Experience

Project Case

FAQ

Q
What is the difference between eukaryotic expression selection CHO cells and 293?
A

1. Cell source: CHO cells are a cell lines derived from the Chinese hamster ovary, while 293 cells are transformed from human embryonic kidney (HEK) cells.

2. Growth characteristics: CHO cells grow rapidly, adapt to a variety of culture conditions, and are easy to expand; while 293 cells have a slower growth rate and require higher culture temperatures and CO2 concentration.

3. Expression ability: CHO cells are widely used in the eukaryotic protein expression, especially in expressing complex proteins such as antibodies, while 293 cells are widely used in the expression of recombinant proteins, viral vectors and other fields.

Q
From the perspective of sequence design, what kinds of sequences are unfavourable for expression?
A

1. High GC content: GC base pairs have strong bonding, which easily leads to stable secondary structures that interfere with transcription and translation.

2. Abnormal promoters and regulatory sequences.

3. Structural domains and translational slow-down regions.

4. Sequences that are difficult to fold stably.

5. Sequences with extensive glycosylation or high cysteine content.

Q
What are the technical differences between large-scale and small-scale antibody expression?
A

1. Culture scale: Large-scale antibody expression typically requires large-scale culturing using larger flasks, bioreactors or fermenters. In contrast, small-scale expression can be performed in smaller vessels such as culture dishes or centrifuge tubes.

2. Cell density control: Large-scale expression requires maintaining high cell density for increased yield which involves optimizing nutrient supply and media compositions. Small-scale setups can operate at lower cell densities, with more focus on protein purification and downstream analysis;

3. Expression optimization: Large-scale production emphasizes optimizing induction conditions, transfection efficiency and culture parameters to maximize yield and purity. In contrast, small-scale expression focuses on maintaining stable expression levels and minimizing cytotoxicity.

4. Protein purification: Large-scale expression generates more protein and typically involves multi-step purification. Small-scale expression often uses simpler techniques such as affinity chromatography or gel filtration.

Q
How can antibody degradation fragments be minimized during expression?
A

1. Use protease-deficient CHO cells or addition of protease inhibitors (e.g. leupastatin).

2. Shorten culture duration and store products at low temperatures (<15℃).

3. Adjust pH (6.8-7.2) to inhibit protease activity.

Q
What is the difference between eukaryotic expression selection CHO cells and 293?
A

1. Cell source: CHO cells are a cell lines derived from the Chinese hamster ovary, while 293 cells are transformed from human embryonic kidney (HEK) cells.

2. Growth characteristics: CHO cells grow rapidly, adapt to a variety of culture conditions, and are easy to expand; while 293 cells have a slower growth rate and require higher culture temperatures and CO2 concentration.

3. Expression ability: CHO cells are widely used in the eukaryotic protein expression, especially in expressing complex proteins such as antibodies, while 293 cells are widely used in the expression of recombinant proteins, viral vectors and other fields.

Q
From the perspective of sequence design, what kinds of sequences are unfavourable for expression?
A

1. High GC content: GC base pairs have strong bonding, which easily leads to stable secondary structures that interfere with transcription and translation.

2. Abnormal promoters and regulatory sequences.

3. Structural domains and translational slow-down regions.

4. Sequences that are difficult to fold stably.

5. Sequences with extensive glycosylation or high cysteine content.

Q
What are the technical differences between large-scale and small-scale antibody expression?
A

1. Culture scale: Large-scale antibody expression typically requires large-scale culturing using larger flasks, bioreactors or fermenters. In contrast, small-scale expression can be performed in smaller vessels such as culture dishes or centrifuge tubes.

2. Cell density control: Large-scale expression requires maintaining high cell density for increased yield which involves optimizing nutrient supply and media compositions. Small-scale setups can operate at lower cell densities, with more focus on protein purification and downstream analysis;

3. Expression optimization: Large-scale production emphasizes optimizing induction conditions, transfection efficiency and culture parameters to maximize yield and purity. In contrast, small-scale expression focuses on maintaining stable expression levels and minimizing cytotoxicity.

4. Protein purification: Large-scale expression generates more protein and typically involves multi-step purification. Small-scale expression often uses simpler techniques such as affinity chromatography or gel filtration.

Q
How can antibody degradation fragments be minimized during expression?
A

1. Use protease-deficient CHO cells or addition of protease inhibitors (e.g. leupastatin).

2. Shorten culture duration and store products at low temperatures (<15℃).

3. Adjust pH (6.8-7.2) to inhibit protease activity.

Project Experience

Project Case

FAQ

Q
What is the difference between eukaryotic expression selection CHO cells and 293?
A

1. Cell source: CHO cells are a cell lines derived from the Chinese hamster ovary, while 293 cells are transformed from human embryonic kidney (HEK) cells.

2. Growth characteristics: CHO cells grow rapidly, adapt to a variety of culture conditions, and are easy to expand; while 293 cells have a slower growth rate and require higher culture temperatures and CO2 concentration.

3. Expression ability: CHO cells are widely used in the eukaryotic protein expression, especially in expressing complex proteins such as antibodies, while 293 cells are widely used in the expression of recombinant proteins, viral vectors and other fields.

Q
From the perspective of sequence design, what kinds of sequences are unfavourable for expression?
A

1. High GC content: GC base pairs have strong bonding, which easily leads to stable secondary structures that interfere with transcription and translation.

2. Abnormal promoters and regulatory sequences.

3. Structural domains and translational slow-down regions.

4. Sequences that are difficult to fold stably.

5. Sequences with extensive glycosylation or high cysteine content.

Q
What are the technical differences between large-scale and small-scale antibody expression?
A

1. Culture scale: Large-scale antibody expression typically requires large-scale culturing using larger flasks, bioreactors or fermenters. In contrast, small-scale expression can be performed in smaller vessels such as culture dishes or centrifuge tubes.

2. Cell density control: Large-scale expression requires maintaining high cell density for increased yield which involves optimizing nutrient supply and media compositions. Small-scale setups can operate at lower cell densities, with more focus on protein purification and downstream analysis;

3. Expression optimization: Large-scale production emphasizes optimizing induction conditions, transfection efficiency and culture parameters to maximize yield and purity. In contrast, small-scale expression focuses on maintaining stable expression levels and minimizing cytotoxicity.

4. Protein purification: Large-scale expression generates more protein and typically involves multi-step purification. Small-scale expression often uses simpler techniques such as affinity chromatography or gel filtration.

Q
How can antibody degradation fragments be minimized during expression?
A

1. Use protease-deficient CHO cells or addition of protease inhibitors (e.g. leupastatin).

2. Shorten culture duration and store products at low temperatures (<15℃).

3. Adjust pH (6.8-7.2) to inhibit protease activity.

Q
What is the difference between eukaryotic expression selection CHO cells and 293?
A

1. Cell source: CHO cells are a cell lines derived from the Chinese hamster ovary, while 293 cells are transformed from human embryonic kidney (HEK) cells.

2. Growth characteristics: CHO cells grow rapidly, adapt to a variety of culture conditions, and are easy to expand; while 293 cells have a slower growth rate and require higher culture temperatures and CO2 concentration.

3. Expression ability: CHO cells are widely used in the eukaryotic protein expression, especially in expressing complex proteins such as antibodies, while 293 cells are widely used in the expression of recombinant proteins, viral vectors and other fields.

Q
From the perspective of sequence design, what kinds of sequences are unfavourable for expression?
A

1. High GC content: GC base pairs have strong bonding, which easily leads to stable secondary structures that interfere with transcription and translation.

2. Abnormal promoters and regulatory sequences.

3. Structural domains and translational slow-down regions.

4. Sequences that are difficult to fold stably.

5. Sequences with extensive glycosylation or high cysteine content.

Q
What are the technical differences between large-scale and small-scale antibody expression?
A

1. Culture scale: Large-scale antibody expression typically requires large-scale culturing using larger flasks, bioreactors or fermenters. In contrast, small-scale expression can be performed in smaller vessels such as culture dishes or centrifuge tubes.

2. Cell density control: Large-scale expression requires maintaining high cell density for increased yield which involves optimizing nutrient supply and media compositions. Small-scale setups can operate at lower cell densities, with more focus on protein purification and downstream analysis;

3. Expression optimization: Large-scale production emphasizes optimizing induction conditions, transfection efficiency and culture parameters to maximize yield and purity. In contrast, small-scale expression focuses on maintaining stable expression levels and minimizing cytotoxicity.

4. Protein purification: Large-scale expression generates more protein and typically involves multi-step purification. Small-scale expression often uses simpler techniques such as affinity chromatography or gel filtration.

Q
How can antibody degradation fragments be minimized during expression?
A

1. Use protease-deficient CHO cells or addition of protease inhibitors (e.g. leupastatin).

2. Shorten culture duration and store products at low temperatures (<15℃).

3. Adjust pH (6.8-7.2) to inhibit protease activity.

Solutions

Rapid Antibody Production

Gram-scale Antibody Production

Antibody+X

Catalog Antibody Products

Applications

Project Experience

Project Case

FAQ

About Us

Promotion

Contact Us

Resources

Privacy Policy

Disclaimer

Contact us

+86 21 3368 1627

protein@sanyoubio.com

abx.sanyoubio.com.cn

T3 Building, No. 559, Zhuyuan Road,
Minhang District, Shanghai

Copyright © 2026 All Rights Reserved Sanyou Biomedical (Shanghai) Co., LTD

Solutions

Rapid Antibody Production

Gram-scale Antibody Production

Antibody+X

Catalog Antibody Products

Applications

Project Experience

Project Case

FAQ

About Us

Promotion

Contact Us

Resources

Privacy Policy

Disclaimer

Contact us

+86 21 3368 1627

abx.sanyoubio.com.cn

protein@sanyoubio.com

T3 Building, No. 559, Zhuyuan Road,<br/> Minhang District, Shanghai

Copyright © 2026 All Rights Reserved Sanyou Biomedical (Shanghai) Co., LTD